QUEST DIAGNOSTICS INC
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Showing the first 6 of 20 trades on this page.
Director
Phantom Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
CEO and President
Common Stock
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
SVP & General Counsel
Common Stock
SVP & General Counsel
Common Stock
SVP & General Counsel
Common Stock
SVP & General Counsel
Common Stock
SVP & General Counsel
Common Stock
The filing reports a zero transaction price for this gift. It does not establish the market value of the gift.
SVP & General Counsel
Non-Qualifed Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
SVP & Chief Commercial Officer
Common Stock
SVP, Clinical Solutions
Common Stock
Director
Common Stock
Director
Common Stock
SVP for Diagnostic Services
Common Stock
Director
Common Stock
Executive Vice President & CFO
Common Stock
Director
Common Stock
SVP & Chief Commercial Officer
Common Stock
Director
Phantom Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
SVP, Clinical Solutions
Common Stock
SVP, Clinical Solutions
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Phantom Stock UnitsGrant or award | Derivative units135Award · no purchase price | Non-cash award | Oct 1Filed Oct 2 · 1d later | SEC filing |
| CEO and President | Common StockSale10b5-1 | 10,000$242.72 / share | $2.43M | Sep 1Filed Sep 3 · 2d later | SEC filing |
| SVP & General Counsel | Common StockOption exercise or conversion10b5-1 | 22,677$112.17 / share | $2.54M | Aug 28Filed Aug 31 · 3d later | SEC filing |
| SVP & General Counsel | Common StockSale10b5-13 trades | 22,677avg $243.11 / share | $5.51M | Aug 28Filed Aug 31 · 3d later | 3 filings
|
| SVP & General Counsel | Common StockGift10b5-1 | 1,000Gift · no purchase price | Not a purchase | Aug 28Filed Aug 31 · 3d later | SEC filing |
| SVP & General Counsel | Non-Qualifed Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units22,677$112.17 exercise / conversion price | Not a separate purchase | Aug 28Filed Aug 31 · 3d later | SEC filing |
| SVP & Chief Commercial Officer | Common StockSale10b5-1 | 1,600$235.18 / share | $376.29K | Jul 28Filed Jul 29 · 1d later | SEC filing |
| SVP, Clinical Solutions | Common StockSmall acquisition | 37$206.81 / share | $7.65K | Jul 22Filed Jul 27 · 5d later | SEC filing |
| Director | Common StockSmall acquisition | 11$206.80 / share | $2.27K | Jul 22Filed Jul 27 · 5d later | SEC filing |
| Director | Common StockGrant or award | 72$206.81 / share | $14.89K | Jul 22Filed Jul 27 · 5d later | SEC filing |
| SVP for Diagnostic Services | Common StockSmall acquisition | 46$206.81 / share | $9.51K | Jul 22Filed Jul 27 · 5d later | SEC filing |
| Director | Common StockSmall acquisition | 21$206.81 / share | $4.34K | Jul 22Filed Jul 27 · 5d later | SEC filing |
| Executive Vice President & CFO | Common StockGrant or award | 102$206.81 / share | $21.09K | Jul 22Filed Jul 27 · 5d later | SEC filing |
| Director | Common StockSmall acquisition | 6$206.81 / share | $1.24K | Jul 22Filed Jul 27 · 5d later | SEC filing |
| SVP & Chief Commercial Officer | Common StockSmall acquisition | 34$206.81 / share | $7.03K | Jul 22Filed Jul 27 · 5d later | SEC filing |
| Director | Phantom Stock UnitsGrant or award | Derivative units144Award · no purchase price | Non-cash award | Jul 1Filed Jul 2 · 1d later | SEC filing |
| SVP, Clinical Solutions | Common StockOption exercise or conversion10b5-1 | 3,320$127.73 / share | $424.05K | Jun 4Filed Jun 8 · 4d later | SEC filing |
| SVP, Clinical Solutions | Common StockOption exercise or conversion10b5-1 | 4,827$121.81 / share | $587.95K | Jun 4Filed Jun 8 · 4d later | SEC filing |
Showing the latest 20 of 42 trades. Show all 42 trades
Quest Diagnostics Incorporated Common Stock (DGX) · Stock
The filing reports a sale for a spouse.
Carol Devine MillerReporting House memberQuest Diagnostics Incorporated Common Stock (DGX) · Stock
The filing reports a sale for a joint account.
Julie JohnsonReporting House memberQuest Diagnostics Incorporated Common Stock (DGX) · Stock
The filing reports a purchase for a joint account.
Julie JohnsonReporting House memberQuest Diagnostics Incorporated Common Stock · Stock
The filing reports a purchase for the member.
Quest Diagnostics Incorporated Common Stock · Stock
The filing reports a purchase for the member.
Quest Diagnostics Incorporated Common Stock (DGX) · Stock
The filing reports a sale for the member.
Julia LetlowReporting House memberQuest Diagnostics Incorporated Common Stock (DGX) · Stock
The filing reports a purchase for the member.
Julia LetlowReporting House memberQuest Diagnostics Incorporated Common Stock (DGX) · Stock
The filing reports a sale for a joint account.
Julie JohnsonReporting House member